References
- Hoffmeister R. T. Methotrexate therapy in rheumatoid arthritis; 15 years' experience. Am J Med 1983; 75(suppl. 7A)69–73
- Wilkens R. F., Watson M. A., Paxson C. S. Low dose pulse methotrexate therapy in rheumatoid arthritis. J Rheumatol 1980; 7: 501–05
- Groff G. D., Shenberger K. N., Wilke W. S., Taylor T. H. Low dose oral methotrexate in rheumatoid arthritis: An uncontrolled trial and review of the literature. Seminars in arthritis and rheumatism 1983; 12: 333–47
- Di Bartolomeo A. G., Mayes M. D., Bathon J. M. Methotrexate in rheumatoid arthritis: A longitudinal study of liver biopsies (Abstr). Arthritis Rheum 1984; 27(suppl.)S61
- McKenzie A. H. Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis. Clive CQ Clin 1985; 52: 129–35
- Lanse S. B., Arnold G. L., Gowans J. D. C., et al. Low incidence of hepatotoxicity associated with longterm, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis and rheumatoid arthritis. An acceptable risk/benefit ratio. Dig Dis Sci 1985; 30: 104–09
- Tolman K. G., Glegg D. O., Lee R. G., Ward J. R. Methotrexate and the liver. J Rheumatol (suppl. 12) 1985; 12: 29–34
- Dahl G. C., Gregory M. M., Scheuer P. J. Methotrexate hepatotoxicity in psoriasis—comparison of different dose regimens. Br Med J 1972; i: 654–6
- Dahl G. C., Gregory M. M., Scheuer P. J. Liver damage due to methotrexate in patients with psoriasis. Br Med J 1971; i: 625–9
- Szanto E. Low dose methotrexate in rheumatoid arthritis: Effect and tolerance. An open trial and a double-blind randomized study. Scand J Rheum 1986; 15(2)97–102
- Roenigk H. H., Jr., Auerbach R., Maibach H. I., Weinstein G. D. Methotrexate guidelines—revised. J Am Acad Dermatol 1982; 6: 145–55
- Whaley K., Williamson J., Dick W. C., et al. Abstract—liver disease in Sjögrens's syndrome and rheumatoid arthritis. Lancet 1970; 861–3
- Schein P. S., Winokur S. H. Immunosuppressive and cytotoxic chemotherapy: long-term complications. Ann Intern Med 1975; 82: 84–95
- Weinblatt M. E., Tesser J. R. P., Gilliam J. H., III. The liver in rheumatic diseases. Semin Arthritis Rheum 1982; 11(4)399–405
- Reese L. T., Grisham J. W., Aach R. D., Eisen A. Z. Effects of methotrexate on the liver in psoriasis. J Invest Dermatol 1974; 62: 597–602
- Hendel J., Poulsen H., Nyfors B., Nyfors A. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes. Acta Pharmacol Toxicol 1985; 56: 321–6
- Whaley K., Webb J. Liver and kidney disease in rheumatoid arthritis. Clin Rheum Dis 1977; 3(3)527–30
- Fernandes L., Sullivan S., McFarlane I. G., et al. Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 501–06
- Kendall M. J., Cocker R., Becker J., Hawkins C. F. Raised serum alkaline phosphatase in rheumatoid disease. Ann Rheum Dis 1970; 29: 537–40
- Spooner R. J., Smith D. H., Bedford D., Beck P. R. Serum gammaglutamintransferase and alkaline phosphatase in rheumatoid arthritis. J Clin Pathol 1982; 35: 638–41
- Lowe J. R., Pickup M. E., Dixon J. S., et al. Gamma glutamyl transpeptidase levels in arthritis: a correlation with clinical and laboratory indices of disease activity. Ann Rheum Dis 1978; 37: 428–31
- Mills P. R., Sturrock R. D. Clinical associations between arthritis and liver diseases. Ann Rheum Dis 1982; 41: 295–307
- Zachariae H., Grunne T. H. E., Sogaard H. Liver biopsy in methotrexate-treated psoriatics—a re-evaluation. Acta Derm Venereol (Stockh) 1975; 55: 291–6
- Editorials. Methotrexate treatment of rheumatoid arthritis. Ann Intern Med 1985; 103(4)612–13
- Nyfors A., Poulsen H. Liver biopsies from psoriatics related to methotrexate therapy. Acta Path Microbiol Scand Sect 1976; 84: 262–70